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Jill Downing, MD, MPH, Gary J. Balady, MD
Boston, Massachusetts
Exercise training in patients with systolic heart failure (HF) is an accepted adjunct to an evidence-based manage-
ment program. This review describes the pathophysiologic features that are thought to be responsible for the
exercise intolerance experienced in the HF patient. Significant research has expanded our appreciation of the
interplay of hemodynamic, ventilatory, and skeletal myopathic processes in this common, chronic condition.
Randomized, controlled exercise trials designed to measure endothelial function, inflammatory markers, sympa-
thetic neural activation, and skeletal muscle metabolism and structure have further defined the pathophysiol-
ogy, documented the impact of exercise training on these processes, and confirmed the benefit of this therapy.
Consistent with prior clinical research and patient experience are the recently published results of the HF-ACTION
(Heart Failure–A Controlled Trial Investigating Outcomes of exercise TraiNing), which demonstrated a modest
improvement in exercise capacity, reduction of symptoms, and improved self-reported measures of quality of life
without adverse events. Consideration is given in this review to the benefits of variable intensity programs and
the addition of resistance exercise to a standard aerobic prescription. Despite increasing validation of the role
exercise training plays in the modification of exercise intolerance, challenges remain in its routine thera-
peutic application, including acceptance and use as an adjunctive intervention in the management of the
patient with HF, limited insurance coverage for HF patients in cardiac rehabilitation, tailoring of exercise
programs to best address the needs of subgroups of patients, and improved short- and long-term adherence
to exercise training and a physically active lifestyle. (J Am Coll Cardiol 2011;58:561–9) © 2011 by the
American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.04.020Prevalence rates for heart failure (HF) have continued to
rise throughout the first decade of the 21st century in the
United States and globally (1). Interwoven in this phenom-
enon is the increasing financial burden at national levels and
the individual disability resulting from this chronic disease,
which is manifest as exercise intolerance due to dyspnea and
fatigue. Advancements in the understanding of oxidative
metabolism and intracellular energy transfer in both skeletal
and cardiac muscle, mechanisms of endothelial dysfunction,
and the role of sympathetic neural activation and inflammatory
cytokines provide possible mechanistic explanations of the
pathophysiologic factors involved in the development of exer-
cise intolerance (Table 1). Elegant, controlled studies de-
signed to evaluate exercise training as a therapeutic inter-
vention in the HF population suggest that many of these
factors improve with training and are associated with
beneficial changes in exercise tolerance. A growing body of
clinical experience and published research data consistently
demonstrates improvement in functional capacity, symp-
toms, and quality of life with exercise training in HF
patients. Furthermore, recent data suggest a modest but
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accepted April 19, 2011.positive impact on repeat hospital stay rates and mortality
reduction (2). The majority of training trials include only
patients with left ventricular (LV) systolic dysfunction.
Because data on exercise in the patient with diastolic HF are
limited to small observational studies with heterogeneous
study populations and variable methods of evaluation, our
discussion is limited in this area.
Impairment of Exercise Capacity in HF
Central circulation. The classic presentation of HF is that
of exercise intolerance due to dyspnea and fatigue. In
attempting to answer the question of exercise intolerance,
consideration has been given to the systems involved in the
exercise response, namely the central circulation, the venti-
latory system, and peripheral vessels and skeletal muscula-
ture. Although abnormalities in the central hemodynamic
response have been described, there remains the paradox
that measures of resting ventricular function—such as ejec-
tion fraction—demonstrate a poor correlation with exercise
capacity (3,4). However, a growing body of studies demon-
strates an improvement in exercise capacity after cardiac
resynchronization therapy, which might be in part due to
the improvement in systolic function rendered by such
treatment (5). The response of the central circulation to
exercise in the patient with systolic HF is characterized by
inadequate LV shortening with increases in end-systolic and
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crease in ventricular filling pres-
sures can give rise to secondary
pulmonary hypertension, result-
ing in right ventricular dysfunc-
tion. Mitral regurgitation can
result if annular dilation or pap-
illary muscle dysfunction is pres-
ent. A decreased cardiac output
at submaximal and peak levels of
effort is a result of a reduction in
stroke volume coupled with a
lower heart rate (HR) reserve (6).
Diastolic dysfunction, if present,
is defined by an increased resis-
tance to ventricular filling. Left
ventricular diastolic filling in-
volves ventricular chamber pres-
sure, compliance, and duration of
diastole. The greater diastolic
filling rate required during exer-
cise is accomplished in the nor-
mal LV by an increase in cham-
ber distensibility, which results in
an increase in LV diastolic vol-
ume without a pressure increase.
With diastolic dysfunction, ven-
tricular distensibility during ex-
ercise is impaired, resulting in a rapid rise in LV diastolic
pressure and pulmonary capillary wedge pressure and the
subsequent experience of dyspnea. Several Doppler-
echocardiographic studies (7–9) have found abnormalities of
LV diastolic function (including the ratio of early diastolic
peak transmitral velocity to myocardial tissue velocity and
ratio of early to late transmitral diastolic velocity) to be
independent predictors of diminished exercise capacity in
those with preserved LV function.
Ventilatory system. Structural abnormalities of the venti-
latory system, including pulmonary vascular damage and
fibrosis from persistent pulmonary venous hypertension
have been demonstrated in patients with HF. Also seen is a
reduction in diaphragmatic strength (10). Despite the ab-
sence of pulmonary congestion, there is an exaggerated
increase in minute ventilation with exercise, out of propor-
tion to the increase in carbon dioxide production (11,12). It
is apparent, however, that ventilatory abnormalities do not
limit peak exercise performance in most patients. Breathing
reserve remains high (13), arterial hypoxia does not gener-
ally occur (6), ventilatory threshold occurs early during
progressive exercise testing (14), systemic and regional
venous oxygen desaturation are maximal (6), and oxygen
uptake (VO2) frequently plateaus—all suggestive of a circu-
latory rather than a pulmonary limitation (Table 2) (15).
The periphery. SKELETAL MUSCLE. With maximal exercise
esting, the HF patient typically reports leg fatigue. This
Abbreviations
and Acronyms
AHA  American Heart
Association
AIT  aerobic interval
training
Ang  angiotensin
BMI  body mass index
CO2  carbon dioxide
HF  heart failure
HR  heart rate
LV  left ventricle/
ventricular
LVEF  left ventricular
ejection fraction
6MWD  6-min walk
distance
NADPH  nicotinamide
adenine dinucleotide
phosphate oxidase
NO  nitric oxide
RAAS  renin-angiotensin-
aldosterone system
ROS  reactive oxygen
species
VO2  oxygen uptakeatigue is associated with increased lactate release from theegs, evidence supportive of skeletal muscle dysfunction.
actate levels correlate closely with maximal exercise capac-
ty, suggesting a link between muscle dysfunction and
xercise intolerance in HF. Heart failure patients have
ecreased muscle mass of the lower extremities. Measured
s thigh cross-sectional area, a modest correlation with peak
xercise capacity has been shown (16). Quantification of
apillary density has varied between studies; however, 1
tudy using cell-specific antibodies to measure capillary
ensity found a significant reduction in microvascular den-
ity when compared with control subjects. In addition,
apillary density correlated with maximal VO2 and total
exercise time (17).
Muscle biopsies of HF patients demonstrate reduced
mitochondrial-based enzymes and mitochondrial size and a
shift in fiber type from slow-twitch, oxidative type I fibers to
fast-twitch, glycolytic type IIb fibers (18–21). Atrophy of
both type IIa and IIb fibers with an increased percentage of
type IIb fibers has been shown. A significant inverse relation
was reported between the percentage of type IIb fibers and
maximal VO2 (22). Skeletal muscle metabolism is abnormal
as well. Magnetic resonance spectroscopy has demonstrated
an impairment of high-energy phosphate transfer during
exercise in the HF patient (23). Skeletal muscle biopsies
performed on HF patients and control subjects matched for
age and peak VO2 showed decreased vascular density and
oxidative enzyme activity in the HF patients that could not
Pathophysiological Mechanisms ofExercise Intolerance in Heart FailureTable 1 Pathophysiological Mechanisms ofExercise Intolerance in Heart Failure
Cardiac
Systolic and/or diastolic dysfunction
Reduced stroke volume
Elevated filling pressures
Secondary pulmonary hypertension and RV dysfunction
Mitral regurgitation
Reduced chronotropic reserve
Ventilatory system
Exaggerated minute ventilation relative to CO2 production
Pulmonary hypertension and resulting pulmonary vascular damage
and fibrosis
Ventilation/perfusion mismatch
Alveolar edema
Skeletal muscle
Reduced muscle mass
Reduced Type IIa fibers relative to Type IIb fibers
Reduced enzymes for oxidative metabolism and generation of ATP
Delayed resynthesis of high-energy compounds
Endothelial function
Reduced nitric oxide
Increased reactive oxygen species
Reduced vasodilatory response to shear stress
Neurohumoral system
Increased sympathetic activity
Low vagal activity
Increased levels of pro-inflammatory cytokinesATP  adenosine triphosphate; CO2  carbon dioxide; RV  right ventricular.
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August 2, 2011:561–9 Exercise and HFbe explained by deconditioning alone (24,25). For a detailed
discussion on skeletal myopathy in HF, the reader is
referred to a recent review by Middlekauff (26).
ENDOTHELIAL FUNCTION. The vascular endothelium plays
n important role in the regulation of arterial tone and,
ence, blood flow to exercising muscles. This occurs
hrough complex mechanisms that stimulate and control the
elease of nitric oxide (NO), a potent vasodilator (27).
elease of NO is stimulated by serotonin, thrombin, ace-
ylcholine, and other receptor-dependent agonists (27) and
lso by increased laminar shear stress, such as occurs during
xercise and is associated with acute increases in pulsatile
lood flow (28–30). The shear stress in turn stimulates
echanotransducers along the endothelium (including what
ave been recently termed “endothelial celia”) (29,30) to
onvert the physical stress of flow to generate multiple
iochemical signals that ultimately lead to the release of
O. Nitric oxide is counterbalanced by oxidative stress and
he release of reactive oxygen species (ROS), which promote
ocal vasoconstriction. The balance or lack thereof (as is
resent among patients with HF) among these many factors
ffects the functional state of the endothelium. Many studies
ave demonstrated evidence of abnormal endothelial func-
ion among patients with HF, which can be mitigated by
xercise training and will be discussed in the following
ext. For a detailed discussion regarding exercise and
ascular biology, the reader is referred to a recent review
y Gielen et al. (31).
NEUROHUMORAL SYSTEM. Other investigative efforts focus
n the neurohumoral systems modulating vascular tone that
re activated in HF, including the renin-angiotensin-
ldosterone system (RAAS) and the sympathetic nervous
ystem. Vasoconstriction and a redistribution of blood
olume with a chronically diminished blood flow to the
xercising muscles have long been described. The RAAS
ctivation results in release of angiotensin (Ang) II, which
as a potent vasoconstrictive effect via activation of Ang II
ype 1 receptor. Ang II also stimulates nicotinamide adenine
Exercise Responses in Patients With Dyspnea Dueto Heart Failure Compared Wi h Pulmonary DiseaseTable 2 Exerci e Responses in Patients With Dyspnea Dueto Heart Failure Compared With Pulmonary Disease
Heart Failure Pulmonary Disease
Peak VO2 Reduced and might plateau Reduced and does not
plateau
Ventilatory threshold Reduced Normal or reduced;
might not be attained
Breathing reserve,
1 – (peak VE/MVV)
20% 15%
Oxygen saturation Normal Often reduced 5%
VE/ VCO2 slope Might be elevated Often elevated
Post-exercise FEV1 Unchanged from rest Might decrease compared
with rest
Reprinted, with permission, from Balady et al. (15).
FEV1  forced expiratory volume in 1 s; MVV  maximum voluntary minute ventilation; VE 
minute ventilation; VE/VCO2  ventilatory equivalent of carbon dioxide; VO2  oxygen uptake.inucleotide phosphate oxidase (NADPH) activity, whichncreases local ROS production. The result is a decrease in
he half-life of endothelium-derived NO and subsequent
ndothelial dysfunction (31). Sympathetic activation causes
urther peripheral vasoconstriction. Catecholamine levels
ise with exercise in patients with HF, but it is not clear
hether this is a contributor to exercise intolerance or an
ndication of advanced disease (32).
INFLAMMATION. The role of inflammatory mediators, such
s tumor necrosis factor and interleukin-6, in the pathogen-
sis of skeletal muscle wasting and fatigue in numerous
linical settings—including HF—is an area of active inves-
igation (33–35). Elevated cytokines have been documented
n HF patients with reduced lower limb muscle mass and
trength (36) and functional class (37). Yet to be defined are
ossible triggers leading to expression of proinflammatory
ytokines, although oxidative stress is felt to play a role (38).
nflammatory cytokines can lead to increased muscle catab-
lism, loss of muscle protein (39), and apoptosis in skeletal
yotubes (40) associated with a decrease in maximal exer-
ise capacity (41).
mpact of Exercise Training
xercise training is recognized as a valuable adjunct in the
herapeutic approach to the stable HF patient and, as such,
s recommended by the American College of Cardiology
nd the American Heart Association (AHA) at a Class 1
evel (42). In control subjects, exercise training can posi-
ively affect maximal VO2, central hemodynamic function,
autonomic nervous system function, peripheral vascular and
muscle function, as well as exercise capacity. These adapta-
tions result in a training effect, allowing an individual to
exercise to higher peak workloads at a lower HR with each
submaximal level of effort (43). Published studies evaluating
the efficacy of exercise training in the HF patient report
improvements of 18% to 25% in peak VO2 and 18% to 34%
in peak exercise duration. Subjective symptoms, functional
class, and quality of life measures improve after training as
well (44). Most exercise training studies in the HF patient
employ moderate- to high-intensity exercise (70% to 80%
peak HR), although a training effect has also been demon-
strated after 8 to 12 weeks of low-intensity training (40% to
50% peak VO2) (23,45).
The recently published findings of the HF-ACTION
(Heart Failure–A Controlled Trial Investigating Out-
comes of exercise TraiNing) lend support to a collective
body of clinical experience and research findings address-
ing efficacy and benefits of exercise training in patients
with HF (2,44,46–52). This was a multicenter, random-
ized, controlled trial designed to measure the effects of
exercise training on clinical outcomes in medically opti-
mized and stable patients with systolic HF (left ventric-
ular ejection fraction [LVEF] 35%). The composite
primary endpoint of the study was all-cause mortality or
all-cause hospital stay. Subjects with New York Heart
Association functional class II to IV symptoms (n  2,331)
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Exercise and HF August 2, 2011:561–9were randomized to either 36 sessions of supervised,
moderate intensity training (60% to 70% HR reserve)
followed by home-based training or usual care. All
subjects were followed for a median of 30 months. A
nonsignificant reduction in the primary combined end-
point of all-cause mortality or hospital stay was found
(hazard ratio: 0.93; p  0.13). However, after adjustment
or pre-specified predictors of mortality (duration of the
ardiopulmonary exercise test; LVEF; Beck Depression
nventory II score; history of atrial fibrillation), the
rimary endpoint became modestly significant (hazard
atio: 0.89; p  0.03). The latter adjustment enabled the
nalysis to more specifically compare patients of similar
isk to increase the statistical power. Additional analysis
evealed no significant difference in mortality (16% vs.
7%) between the exercise and control group, respec-
ively. There was a modest but significant improvement
n measured peak VO2 in the exercise group compared
ith the control group (0.6 ml/kg/min vs. 0.2 ml/kg/min,
espectively) at 3 months, which was similar at 1 year. In
he exercise training group, the median improvement in
easured peak VO2 was only 4%; a level much lower than
that reported in other, smaller training studies. However,
these findings must be viewed in the context of the
generally low rate of adherence to exercise in the training
group, whereby only 30% of subjects exercised at or above
the target number of min/week. Moreover, it is estimated
that at least 8% of the control patients admitted to
exercising throughout the entire study period. These
factors might account for the limited improvement in
exercise tolerance in the exercise group and attenuate
differences in outcomes between the exercise and control
groups (2).
The HF-ACTION study provides the largest single
study where the safety of exercise in patients with stable HF
can be assessed. Exercise training was generally well-
tolerated and safe, a finding consistent with earlier, small,
single-center studies showing adverse event rates to be low
but lacking adequate numbers to evaluate mortality and
morbidity as well as control subjects in many cases (46).
Details of the reported events are provided in Table 3.
Notably, of 490 patients with an implantable cardiac defi-
brillator in the exercise group, only 1 experienced implant-
able cardiac defibrillator firing during an exercise session.
Overall, the adverse event rates during the entire study
period did not differ between the exercise and control
groups (2).
Central hemodynamic adaptations. Exercise training
does not seem to improve cardiac output during submaximal
exercise in patients with HF (21,53,54). Most studies show
no change in resting LVEF, although 2 studies have
demonstrated a slight increase in cardiac output at peak
levels of exercise (53,55), and reductions of resting LV
end-diastolic diameter, suggesting a training-induced re-
verse remodeling (55). Ventilatory threshold, a reproduc-
ible, nonvolitional measure of cardiovascular fitness is de- dlayed with training and occurs at a higher VO2. Pulmonary
rtery pressure, pulmonary capillary wedge pressure, and
ystemic vascular resistance are usually unchanged after
raining either at rest or during exercise (53,56).
Effects of exercise training on LV diastolic function in
atients with systolic dysfunction have included a significant
eduction in LV diastolic wall stress at low work rates (50%
eak VO2). Training at this lower work rate resulted in a
0% increase in peak VO2 after 2 months (57). In 1 study,
4 HF patients were randomized to 3 months of exercise
raining or to a control group. Calculations of elastance with
oppler echo diastolic measures showed a 27% reduction
ith exercise, with no change in ventricular volumes, mean
lood pressure, or LVEF (58). In another study that
valuated patients with dilated cardiomyopathy and a
oppler mitral inflow profile suggestive of concomitant
bnormal diastolic LV function, only those with delayed
elaxation improved their functional capacity after training.
n these latter patients, the diastolic filling pattern normal-
zed after training. Those with a restrictive filling pattern,
owever, were found to have a worse prognosis and did not
mprove functional capacity or diastolic filling pattern after
raining (59).
eripheral adaptations. Abnormalities of both skeletal
uscle and vasomotor tone characteristic of HF patients can
e reversed with exercise training (20,22). Exercise training
an improve the volume density of mitochondria and the
olume density of cytochrome c oxidase-positive mitochon-
Summary of Selected Adverse Eventsin the HF-ACTION Study*Table 3 ummary of Selected Adverse Eventsin the HF-ACTION Study*
Adverse Events
Usual Care
(n  1,171)†
Exercise Training
(n  1,159)
Pre-specified cardiovascular adverse events
Worsening HF 340 (29.0) 303 (26.1)
Myocardial infarction 45 (3.8) 41 (3.5)
Unstable angina 88 (7.5) 86 (7.4)
Serious adverse arrhythmia‡ 164 (14.0) 167 (14.4)
Stroke 28 (2.4) 33 (2.8)
Transient ischemic attack 23 (2.0) 20 (1.7)
Any of the above events 471 (40.2) 434 (37.4)
General adverse events
Hospital stay for fracture of hip or pelvis 7 (0.6) 3 (0.3)
Outpatient fracture repair 20 (1.7) 13 (1.1)
ICD firing§ 151/644 (23.4) 142/641 (22.2)
Hospital stay after exercise 22 (1.9) 37 (3.2)
Died after exercise¶ 5 (0.4) 5 (0.4)
Values are n (%). There were no differences in adverse events between the treatment groups.
*Unless otherwise indicated. †Follow-up data forms were not available for 1 patient. ‡Defined as
sustained ventricular tachycardia lasting longer than 30 s, ventricular fibrillation, supraventricular
tachycardia with rapid ventricular response lasting longer than 30 s, cardiac arrest, or bradycardia
(heart rate50 beats/min, symptomatic, and not felt to be related to medication). §Indicates the
number fired/number of patients with an implantable cardioverter-defibrillator (ICD) (percentage).
Had at least 1 hospital stay due to an event that occurred within 3 h after exercise. ¶Patient died
or not known whether patient died during or within 3 h after exercise. Reprinted, with permission,
from O’Connor et al. (2).
HF  heart failure; HF-ACTION  Heart Failure–A Controlled Trial Investigating Outcomes of
exercise TraiNing.ria with an increase in expression of oxidative metabolic
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August 2, 2011:561–9 Exercise and HFenzymes (19–21). A return to type I oxidative fibers (a shift
from type II) is seen on muscle biopsy (60). Peak exercise leg
blood flow and leg arterio-venous oxygen difference are
reported to increase after training (54). A decrease in leg
venous lactate levels seems to be inversely related to the
changes in mitochondrial volume density and not leg blood
flow (60). Studies have documented improvements in endo-
thelial function with exercise training. Endothelial function—
evaluated by measuring brachial artery flow-mediated
ilation—after handgrip exercise in HF patients normal-
zed. After administration of a NO synthase blocking
gent, flow attenuation suggested a NO-mediated train-
ng effect (60). Similar improvements in femoral artery
ow were found in HF patients randomized to upright
ycle exercise or usual activity. Endothelium-dependent
hange in peripheral blood flow was significantly corre-
ated with a 26% increase in peak VO2 (61).
NEUROHORMONAL ADAPTATIONS. Activation of RAAS
esulting in vasoconstriction is another target of investi-
ation in vascular disease. One study looked at the impact
f regular physical activity on Ang II-mediated vasocon-
triction mediated by Ang II-induced NADPH oxidase
ctivation and ROS production (62). The messenger
ibonucleic acid expression of NADPH oxidase activity
nd ROS generation were all significantly lower in the
raining group and associated with an improvement in
cetylcholine-mediated vasodilation. Another study dem-
nstrated that exercise training increases the vascular
xpression of anti-oxidative radical scavenger enzymes,
ncluding catalase and glutathione peroxidase (63). Al-
hough similar exercise effects remain to be demonstrated
n HF patients and correlated with an improvement in
unctional capacity, it is plausible that similar mecha-
isms of endothelial dysfunction and regulation exist in
oth patient groups.
The evaluation of the effects of exercise training on
ympathetic nervous activity in HF includes assessment of
lasma norepinephrine levels, HR variability, and whole-
ody norepinephrine spillover. Although results vary among
tudies, most demonstrate the beneficial effects of enhanced
agal tone and decreased sympathetic tone with exercise
raining (44,64–66). These findings demonstrate that,
hen directly measured, there is a decrease in sympathetic
erve activity with exercise training in HF patients. To
valuate the ergoreceptor contribution to exercise in HF,
ynamic handgrip and 3-min post-handgrip regional circu-
atory occlusion was evaluated in HF patients and control
ubjects. After 6 weeks of forearm training, ergoreflex
ontributions—as measured by HR variability, changes in
iastolic pressure, leg vascular resistance, and ventilation—
ere reduced more in HF patients (67).
EFFECTS ON INFLAMMATION. Controlled trials of exercise
training also demonstrate reduced levels of the inflamma-
tory cytokines tumor necrosis factor-alpha and interleukin-6
after training and a correlation with an improvement in peakVO2 (27,68). These observations suggest that inflammatory
ediators are involved in the skeletal muscle myopathy of
F and the consequent experience of fatigue and exercise
ntolerance.
raining considerations. The standard recommendations
or exercise training in general include aerobic activity
erformed at least 30 min, 5 or more days/week, with
pecific parameters that define exercise intensity, duration,
nd frequency. Exercise intensity in HF training has varied
etween studies, and some study protocols have used inter-
al or variable intensity training. Practice guidelines (69)
romote the development of individual exercise prescription
n the basis of an objective measurement of functional
apacity. In most clinical settings, an intensity range of 70%
o 80% of peak HR determined from a symptom-limited
xercise test is used. Exercise training research has examined
he additional benefits of high-intensity exercise compared
ith low- to moderate-intensity exercise in a variety of
opulations (57,70,71). Recently, a seminal study has eval-
ated the effect of aerobic interval training (AIT), which
nvolves alternating 3- to 4-min periods of exercise at
igh intensity (90% to 95% HRpeak) with exercise at moderate
ntensity (60% to 70% HRpeak) among patients with post-
infarction HF. This comprehensive assessment included mea-
sured aerobic capacity, measures of LV remodeling, skeletal
muscle mitochondrial function, and endothelial function. Pa-
tients were randomized to AIT, moderate continuous training
(70% peak HR), or usual activity. The VO2 increased more
with AIT and was associated with reverse LV remodeling
(increase in LVEF, decrease in LV volumes, and decrease in
pro-brain natriuretic protein). Endothelial function demon-
strated greater improvement with AIT, and mitochondrial
function increased only with AIT (71). A recent small
randomized study has shown that 3 months of progressive
training at high exercise intensities of 80% to 90% of peak
HR yielded significant additional improvement in peak
VO2, beyond that attained after cardiac resynchronization
therapy (5).
Modality of training is another consideration. Although
aerobic exercise remains the mainstay of clinical training
programs, resistance training has also shown benefits (72),
including improved muscle strength, endurance, and blood
flow associated with a lower VO2 at submaximal workloads
(73,74). In 2 small studies that randomized HF patients to
either resistance exercise or usual activity (75,76), echocar-
diographically determined LV volumes remained un-
changed, and modest improvements in resting LVEF were
noted after 8 weeks of training, thus suggesting that
resistance exercise has no deleterious effects on LV function
or structure. A summary of published resistance training
studies in HF is provided in Table 4 (77–82). The beneficial
effects of exercise in patients with HF are summarized in
Table 5.
ADHERENCE TO TRAINING. Despite ample evidence of
benefit, the experience—assuming that exercise is even
F
p nce; SV
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Exercise and HF August 2, 2011:561–9initiated—is that adherence to exercise training is not
maintained. The observation that only 30% of the 1,159
subjects in the training group of the HF-ACTION study
were adherent to the program as prescribed is sobering in
the context of the close monitoring and surveillance pro-
vided to these patients by the study investigators.
A Cochrane review of publications since June 2001
evaluating interventions aimed at improving enrollment
(uptake) and adherence to cardiac rehabilitation programs
and their components found few practice recommendations
could be made, although those targeting individual patient
barriers might increase success (83). Individual obstacles to
exercise that need to be evaluated and possibly mitigated
Summary of Resistance Training Studies in HFTable 4 Summary of Resistance Training Studies in HF
First Author (Ref. #) n Age (yrs)/Sex
McKelvie et al. (81) 10 exercise
No control subjects
Age not provided
Men only
Hare et al. (82) 9 exercise
No control subjects
Mean age 63
Men only
Oka et al. (79) 20 exercise
20 control subjects
Age 30–76
23 men/
17 women
Pu et al. (77) 9 exercise
7 control subjects
Mean age 76
Women only
Selig et al. (73) 10 exercise
20 control subjects
Mean age 65
33 men/
6 women
Levinger et al. (76) 8 exercise
7 control subjects
Mean age 56
Men only
Beckers et al. (74) 28 AT/RT
30 AT only
Mean age 58
42 men/
16 women
Palevo et al. (75) 10 exercise
6 control subjects
Mean age 68
Men only
Swank et al. (80) 42 exercise
No control subjects
Age not provided
27 men/
15 women
Maiorana et al. (78) 12 RT
12 AT
12 control subjects
Mean age 61
32 men/
4 women
AE adverse events; AT aerobic training; CV cardiovascular; DBP diastolic blood pressure; E
X function; HF heart failure; HRV heart rate variability; LVEDD left ventricular end-diastolic d
ressure product; RT  resistance training; SBP  systolic blood pressure; 6MWD  6-min walk dista
Beneficial Effects of Exercise in Heart FailureTable 5 Beneficial Effects of Exercise in Heart Failure
Aerobic training Increased exercise capacity (2,54)
Lower heart rate response to submaximal exercise (54)
Improved diastolic function (57–59)
Improved endothelial function (61,62)
Increased skeletal muscle oxidative capacity (19,20,60)
Enhanced vagal tone and lower sympathetic tone
(65,66)
Reduced inflammatory cytokines (27,68)
Lower all-cause mortality or hospital stay (2,45)
Improved health status (44,45,47)Resistance training Increased muscle strength and endurance (73,75,82)include such things as physical and psychological comor-
bidities, musculoskeletal limitations of aging, impaired cog-
nition, sleep disturbances, and poor health literacy. Even
discounting any recent inactivity due to HF itself, the
majority of HF patients referred to a cardiac rehabilitation
program for exercise training begin at a completely seden-
tary baseline of activity (84,85). Exercise is being introduced
as a new behavior, and as with all behavior change, many
factors are involved in successfully initiating and maintain-
ing it for the long term. In a recent AHA Scientific
Statement (84) aimed at improving outcomes from chronic
conditions such as HF, the concept of self-care is described.
Addressing the necessary knowledge base, behavioral skills,
and social supports required of an individual to monitor
their health status and make appropriate decisions, self-care
addresses some of the challenges experienced in exercise
initiation and maintenance. Further emphasis on self-care
might serve as a framework for future tailored interventions
in this area.
Challenges other than those related to the individual
patient include professional and programmatic ones. Refer-
ral rates from practitioners remain low, despite a strong
recommendation by both the AHA and American College
of Cardiology that exercise be considered a beneficial
adjunctive treatment in patients with current or prior
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ysfunctisymptoms of HF and reduced LVEF (42). Perhaps one of
567JACC Vol. 58, No. 6, 2011 Downing and Balady
August 2, 2011:561–9 Exercise and HFthe greatest obstacles to referral is that HF is still not
considered a qualifying diagnosis for cardiac rehabilitation
benefits by Medicare, the major provider of healthcare
reimbursement for this population in the United States.
Although the body of evidence to support such coverage is
large, continued advocacy by professional organizations and
providers of cardiac rehabilitation to include HF as a
qualifying diagnosis is needed. Additional cost-effectiveness
studies that evaluate exercise training as a component of a
comprehensive multifaceted HF management program will
no doubt assist in this effort, especially in this time of
increased accountability for care and constrained fiscal
resources.
Summary
A preponderance of the evidence supports the benefits and
safety of an exercise training program for the stable, systolic
HF patient who is receiving optimal medical treatment.
Functional capacity improves, symptoms of dyspnea and
fatigue diminish, and self-reported quality of life benefits.
Several small randomized exercise training trials have dem-
onstrated not only an improvement in peak exercise capacity
but a modification of multiple measures of metabolic func-
tion, vascular tone, cytokine production, and neural activa-
tion. All suggest a positive and important role for exercise in
the interruption and improvement in the major limiting
symptom of HF, namely exercise intolerance. Although
repeat hospital stay rates and mortality are only modestly
improved as a combined endpoint, data regarding the latter
might be limited because of the high rate of nonadherence
to the exercise program in the training group (2). In an
effort to extend the benefits of exercise training to a greater
number of HF patients, we must address such issues as
providing cardiac rehabilitation as a covered insurance
benefit for the diagnosis of HF; improving the rate of
referral and enrollment of such patients in cardiac rehabil-
itation programs; further defining training programs with
regard to recent data on intensity and modality to optimize
functional outcome; and finally, employing methods that
optimize adherence to exercise and thus generate the
greatest yield of benefits that range from the cellular level
to exercise tolerance, the quality and perhaps the length
of life.
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